Virtual Rheumatology Clinic Among Top Innovators Chosen from 300+ Applicants
LAS VEGAS (October 2024) – Rheumission, a first-of-a-kind virtual clinic transforming autoimmune rheumatology care, has been selected as a finalist for the Provider Care Coordination Pitch Competition at HLTH 2024. The competition, sponsored by TGH Ventures, the corporate venture arm of Tampa General Hospital, showcases innovative solutions that are transforming healthcare delivery and patient outcomes.
Rheumission was chosen from a competitive field of over 300 applicants, distinguishing itself with its cutting-edge, evidence-based approach to autoimmune care. The company's innovative platform combines multidisciplinary integrative rheumatology and lifestyle medicine care team coordination, and personalized interventions to address the rising costs and complexity of autoimmune rheumatology condition diagnosis and management.
"Being selected as a finalist for the HLTH 2024 pitch competition validates our mission to revolutionize rheumatology care delivery," said Dean Sawyer, CEO of Rheumission. "Our virtual-first model is designed to make specialized care more accessible with better outcomes, while reducing costs for specialty medication spend."
Rheumission will present its solution at HLTH 2024 on Tuesday, October 22nd, from 2:30 - 4:00 pm PT on the Startup Stage in Las Vegas, Nevada. The competition highlights solutions that improve communication, streamline processes, and enhance patient outcomes while seamlessly integrating with existing healthcare systems.
The Provider Care Coordination Pitch Competition offers finalists the opportunity to showcase their innovations before industry leaders and potential investors, with the winner receiving funding and potential partnership opportunities with Tampa General Hospital.
About Rheumission
Rheumission is the first virtual rheumatology clinic offering specialized, integrative, whole-person care covered by insurance. Launched in January 2024, our mission is remission: to change the lives of people with autoimmune disease, which affects 50 million people in the US, 80% of which are women. For more information, visit www.rheumission.com.
About HLTH
HLTH is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation. The HLTH conference gathers top health industry leaders and creates unique opportunities for innovation and collaboration each year.